Dear Colleagues,
We would like to bring to your attention the 2nd Introductory Training Course on
'Pharmacokinetics and Pharmacodynamics of Protein Therapeutics - Concepts and
Hands-On Modeling and Simulation'
The course will be held at the facilities of the University of Tennessee Health
Science Center in Memphis, TN, USA, on April 16-20, 2012.
The 5-day course will introduce participants to basic principles in the
pharmacokinetic and pharmacodynamic evaluation of novel protein therapeutics
and provide opportunities for hands-on PK and PK/PD modeling and simulation
examples relevant for protein drugs. Topics include target-mediated drug
disposition, tissue and tumor penetration, interspecies scaling, first-in-human
dose selection, immunogenicity, model-based drug development, disease
progression modeling, and drug-drug interactions. The target audience comprises
pharmaceutical scientists from industry, academia and regulatory agencies with
basic knowledge in PK and PKPD that had only limited exposure to the challenges
associated with developing protein therapeutics and that would like to receive
a comprehensive first overview or refresher on the PK and PKPD of this class of
compounds.
For more detailed information on the course program and registration, please
visit
http://www.PKPDofProteinTherapeutics.com
We hope you will join us in April in Memphis!
The Course Directors
Bernd Meibohm, University of Tennessee & Johan Gabrielsson, AstraZeneca